+44 (0) 1223 755950
+1 832 327 7413
UDP Glucose Ceramide Glucosyltransferase (UGCG) Protein
REQUEST MORE INFO
Catalogue No: abx655856
Price:
US$725.00
(Size: 50 µg)
Reviews: 
(0 Publications and Reviews)
(0 Publications and Reviews)
Click on the image to see the image legend
Human, Mouse, Rat UDP Glucose Ceramide Glucosyltransferase (UGCG) Protein (Active) is an Active Recombinant Human, Mouse, Rat protein.
Research Articles on UDP Glucose Ceramide Glucosyltransferase (UGCG)
| Target | UDP Glucose Ceramide Glucosyltransferase (UGCG) |
| Origin | Human, Mouse, Rat |
| Expression | Recombinant |
| Tested Applications | WB, SDS-PAGE |
| Host | E. coli |
| Conjugation | Unconjugated |
| Form | Lyophilized |
| Purity | > 95% |
| Reconstitution | Reconstitute in ddH2O to a concentration up to 0.05 mg/ml. Do not vortex. |
| Storage | Store at 2-8 °C for up to one month. Store at -80 °C for up to one year. Avoid repeated freeze/thaw cycles. |
| Molecular Weight | Calculated MW: 16.1 kDa Observed MW (SDS-PAGE): 16 kDa |
| Sequence Fragment | Lys39-Leu171 |
| Sequence | KK ATDKQPYSKL PGVSLLKPLK GVDPNLINNL ETFFELDYPK YEVLLCVQDH DDPAIDVCKK LLGKYPNVDA RLFIGGKKVG INPKINNLMP GYEVAKYDLI WICDSGIRVI PDTLTDMVNQ MTEKVGLVHG L |
| Tag | N-terminal His tag |
| Buffer | Prior to lyophilization: 20 mM Tris, 150 mM NaCl, pH 8.0, containing 0.01% Sarcosyl and 5% Trehalose. |
| Activity | Active |
| Biological Activity | UDP Glucose Ceramide Glucosyltransferase (UGCG) is an enzyme which catalyzes the first glycosylation step in glycosphingolipid biosynthesis. It belongs to the glycosyltransferase 2 family. UGCG is widely expressed and transcription is upregulated during keratinocyte differentiation. Besides, Large Multifunctional Peptidase 2 (LMP2) has been identified as an interactor of UGCG, thus abinding ELISA assay was conducted to detect the interaction of recombinant human UGCG and recombinant human LMP2. Briefly, UGCG were diluted serially in PBS, with 0.01% BSA (pH 7.4). Duplicate samples of 100 µl were then transferred to LMP2-coated microtiter wells and incubated for 2 h at 37 ℃. Wells were washed with PBST and incubated for 1 h with anti-UGCG pAb, then aspirated and washed 3 times. After incubation with HRP labelled secondary antibody, wells were aspirated and washed 3 times. With the addition of substrate solution, wells were incubated 15-25 minutes at 37 ℃. Finally, add 50 µL stop solution to the wells and read at 450 nm immediately. The binding activity of UGCG and LMP2 was shown in Figure 4, and this effect was in a dose dependent manner. |
| Endotoxin Level | < 1.0 EU/ml (LAL method) |
| Concentration | Prior to lyophilization: 500 µg/ml |
| Availability | Shipped within 5-7 working days. |
| Note | This product is for research use only. Not for human consumption, cosmetic, therapeutic or diagnostic use. |
